Many countries have published clinical practice guidelines for appropriate clinical decisions, optimal treatment, and improved clinical outcomes in patients with acute coronary syndrome. Developing guidelines that are specifically tailored to the Korean environment is crucial, considering the treatment system, available medications and medical devices, racial differences, and level of language communication. In 2017, the Korean Society of Myocardial Infarction established a guideline development committee. However, at that time, it was not feasible to develop guidelines, owing to the lack of knowledge and experience in guideline development and the absence of methodology experts. In 2022, the National Evidence-Based Healthcare Collaborating Agency collaborated with a relevant academic association to develop internationally reliable guidelines, with strict adherence to the methodology for evidence-based guideline development. The first Korean acute coronary syndrome guideline starts from the 9 key questions for pharmacotherapy.

美国结肠直肠外科学会（ASCRS）致力于通过推进结肠、直肠和肛门疾病的科学、预防和管理来确保高质量的患者护理。临床实践指南（CPG）委员会由社会成员组成，他们被选中是因为他们在结肠和直肠手术方面表现出专业知识。该委员会的成立是为了领导国际努力，确定结肠、直肠和肛门相关疾病的质量护理，并根据现有的最佳证据制定CPG。这些准则虽然不是禁止性的，但提供了可以作出决定的资料，并没有规定具体的治疗形式。这些指南适用于所有从业人员、卫生保健工作者和患者，他们希望了解这些指南所涵盖的主题所涉及的疾病的管理信息。本指南不应被视为包括所有适当的护理方法，也不应排除合理导向获得相同结果的护理方法。关于任何特定程序的适当性的最终判断必须由医生根据患者个人的所有情况作出。